The global market for injectable drug delivery devices is forecasted to experience substantial growth in the next several years. Manufacturers are rolling out new technology and innovative products to make administration easier, boost compliance, and improve overall convenience. In this Drug Development & Delivery report, we take a closer look at injectables that are under development or have been newly launched in the market.
Owen Mumford Pharmaceutical Services focused this past year on their passive safety syringes. “We have added a 2.25mL device to expand our UniSafe platform,” explains Michael Earl, Director of Owen Mumford Pharmaceutical Services. You can read more about this device on page 52.